Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium
Influenza is a significant global health problem, causing disease and hospitalisations in elderly individuals and infants. While updated vaccines are available every year, their effectiveness is moderate at best. FLUniversal is a European Union funded …